Skip to main content
Log in

Plasma protein binding of prednisolone in normal volunteers and arthritic patients

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The plasma binding of prednisolone was studied in twenty normal volunteers and twenty rheumatoid arthritis patients. An in vitro assessment of the binding following the addition of prednisolone, prednisone, and hydrocortisone to the plasmas obtained from the subjects showed significant differences in the percentage of prednisolone bound. However, the differences observed were regarded as clinically insignificant. The plasma protein binding was determined by an in vitro equilibrium dialysis of the individual plasma samples at 37° C. Prednisolone levels on both sides of the dialysis membrane were determined using radioactivity and HPLC analytical methodologies. The percentages of prednisolone bound calculated from the analytical results of either the radiochemical or HPLC method were not significantly different. The change in the percentage of prednisolone bound to plasma proteins was studied as a function of the total prednisolone plasma concentration in a normal volunteer and in a systemic lupus erythematosis patient. As a result of prednisolone binding to both transcortin and albumin, the binding of prednisolone changes as a function of prednisolone concentration. The binding data were fitted using nonlinear least squares regression, and the affinity constants for the binding of prednisolone to transcortin and albumin were estimated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Powell, L. W., Axelson, E.: Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein binding. Gut13, 690–696 (1972)

    Google Scholar 

  2. Jenkins, J. S., Sampson, P. A.: Conversion of cortisone to cortisol and prednisone to prednisolone. Br. Med. J.1967/II, 205–207

    Google Scholar 

  3. Gennaro, A. R., Guttman, D. E.: Complexation. In: Remington's Pharmaceutical Sciences, XV. Osol, A., Hoover, J. E., (eds.), pp. 206–210. Easton: Mack Publishing Co. 1975

    Google Scholar 

  4. Lewis, G. P., Jusko, W. J., Burke, C. W., Graves, L.: Prednisone side-effects and serum-protein levels. Lancet1971/II, 778–780

    Google Scholar 

  5. Jusko, W. J.: Pharmacokinetics in disease states changing protein binding. In: The Effect of Disease States on Drug Pharmacokinetics. Benet, L. Z. (ed.), pp. 99–123. Washington: American Pharmaceutical Association, Academy of Pharmaceutical Sciences 1976

    Google Scholar 

  6. Rocci, M. L., Jusko, W. J.: Animal model for dose dependent protein binding and disposition of prednisolone. In: Abstracts Papers. Vol. 8, p. 89. Washington: American Pharmaceutical Association, Academy of Pharmaceutical Sciences 1978

    Google Scholar 

  7. Westphal, U.: Corticosteroid-binding globulin and other stcroid-binding serum proteins. In: Methods in Enzymology, XV. Steroids and Terpenoids. R. B. Clayton (ed.), pp. 761–796. New York, London: Academic Press 1969

    Google Scholar 

  8. Westphal, U.: Steroid-protein interactions. XIII. Concentrations and binding affinities of corticosteroid-binding globulins in sera of man, monkey, rat, rabbit, and guinea pig. Arch. Biochem. Biophys.118, 556–567 (1967)

    Google Scholar 

  9. Angeli, A., Frajria, R., Depaoli, R., Fonzo, D., Ceresa, F.: Diurnal variations of prednisolone binding to serum corticosteroid-binding globulin in man. Clin. Pharmacol. Ther.23, 47–53 (1978)

    Google Scholar 

  10. Turner, A. K., Carroll, C. J., Pinkus, J. L., Charles, D., Chattoraj, S. C.: Simultaneous competitive protein binding assay for cortisol, cortisone, and prednisolone in plasma, and its clinical applications. Clin. Chem.19, 731–736 (1973)

    Google Scholar 

  11. Metzler, C. M.: A user's manual for NONLIN, technical report 7292/69/7292/005. The Upjohn Co., Nov. 25, 1969

  12. Sullivan, T. J., Hallmark, M. R., Sakmar, E., Weidler, D. J., Earhart, R. H., Wagner, J. G.: Comparative bioavailability: Eight commercial prednisone tablets. J. Pharmacokinet. Biopharm.4, 157–172 (1976)

    Google Scholar 

  13. Chesrow, E. J., Bronsky, D., Orfei, E., Dyniewicz, H., Durbin, A., Musci, J.: Serum proteins in the aged. Geriatrics13, 20–24 (1958)

    Google Scholar 

  14. Levy, G.: Clinical pharmacokinetics of aspirin. Pediatrics62, 867–872 (1978)

    Google Scholar 

  15. Meloun, B., Moravek, L., Kostka, V.: Complete amino acid sequence of human serum albumin. FEBS Lett.58, 134–137 (1975)

    Google Scholar 

  16. Evans, P. H.: The effect of drugs on serum sulfhydryl levels in rheumatoid disease. Scand. J. Rheumatol.6, 69 (1977)

    Google Scholar 

  17. Reid, R. T., Farr, R. S.: Further evidence for albumin alterations in some patients with rheumatic disease. Arthritis Rheum.7, 747–748 (1964)

    Google Scholar 

  18. Hinchen, J. D.: Practical statistics for chemical research, p. 25. London: Methuen and Co. Ltd. 1969

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ağabeyoğlu, I.T., Bergstrom, R.F., Gillespie, W.R. et al. Plasma protein binding of prednisolone in normal volunteers and arthritic patients. Eur J Clin Pharmacol 16, 399–404 (1979). https://doi.org/10.1007/BF00568200

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00568200

Key words

Navigation